Simenafil Hydrochloride

盐酸司美那非

Report date: 2026/01/28 16:50:21
NME

Base Information

Drug NameSimenafil Hydrochloride
Drug Alias Name斯美瑞非Simmerafil hydrochloride昂伟达ONVITAOnvita +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsErectile DysfunctionPulmonary Arterial Hypertension
Global Approved IndicationsErectile Dysfunction
Approved Indications in ChinaErectile Dysfunction
Original Approved Country/TerritoryUzbekistan
Original Approved Date2022/09/01
Country/TerritoryUzbekistanMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTopharman Shanghai Co LtdSuzhou Vigonvita Life Sciences Co LtdShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShandong Tefaman Pharmaceutical Co LtdSuzhou Vigonvita Life Sciences Co LtdShanghai Institute Of Materia Medica, Chinese Academy Of Sciences +[4] 
Inactive CompaniesN/A
Active IndicationsErectile DysfunctionPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A